Inflammatory Diseases

Gilead Sciences and Arcus Biosciences expand to include inflammation research programs

15-May-2023 By Liza Laws

A previously announced research collaboration between Gilead Sciences and Arcus Biosciences that was focused on oncology has been expanded to include inflammatory diseases therapies.

Pfizer offers full portfolio on not-for-profit basis to low-income countries

25-Jan-2023 By Ben Hargreaves

The company confirms that its ‘An Accord for a Healthier World’ initiative will be rolled out to 45 lower-income countries.

Sun Pharma spends $576m to get hands on hair loss drug

24-Jan-2023 By Ben Hargreaves

The Indian company decides to purchase Concert Pharmaceuticals, which is developing deuruxolitinib as a potential treatment for alopecia areata.

DIA Annual Meeting 2021

DIA 2021 will explore the potential of RNA based therapeutics

17-Jun-2021 By Jane Byrne

In recent years, it has become clear that RNA molecules are an emerging as a class of therapeutics of relevance to multiple diseases, most recently including COVID-19 vaccines.